Bioceltix S.A. (WSE:BCX)
Poland · Delayed Price · Currency is PLN 68.00
-1.20 (-1.73%)
Oct 15, 2026, 12:54 PM CET
Bioceltix Market Cap
Bioceltix has a market cap or net worth of 376.19 million as of October 14, 2026. It is the 25,432nd most valuable company in the world and the 151st biggest in Poland. Its market cap has decreased by 18.30% in one year.
Market Cap
376.19M
Enterprise Value
319.53M
Revenue
n/a
Global Rank
Country Rank
#151 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, Bioceltix's market cap has increased from 115.04M to 376.19M, an increase of 227.02%. That is a compound annual growth rate of 27.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 376.19M | -1.56% |
| Dec 30, 2025 | 382.14M | -11.42% |
| Dec 30, 2024 | 431.38M | 16.07% |
| Dec 29, 2023 | 371.65M | 179.48% |
| Dec 30, 2022 | 132.98M | -22.49% |
| Dec 30, 2021 | 171.57M | 49.14% |
| Nov 8, 2021 | 115.04M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 560.41M |
| Ryvu Therapeutics | 390.73M |
| Captor Therapeutics Spolka Akcyjna | 381.20M |
| BIOTON | 326.28M |
| Synthaverse | 211.40M |
| Molecure | 131.45M |
| Mabion | 128.81M |
| Poltreg | 115.67M |